Global CRISPR Screening Market Analysis 2026–2030 Offering Strategic Insights for Businesses
The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Expected Market Size Of The Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market In 2026 And How Much Will It Reach By 2030?
The market size for arrayed clustered regularly interspaced short palindromic repeats (crispr) screening has seen rapid growth recently. It is forecast to increase from $1.52 billion in 2025 to $1.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.5%. The expansion witnessed in prior periods can be attributed to the broader scope of functional genomics research, the availability of crispr editing reagents, the development of academic screening programs, the early adoption of arrayed screening methods, and the increased application of cell-based assays.
The arrayed clustered regularly interspaced short palindromic repeats (crispr) screening market size is forecast to experience significant growth in the upcoming years, reaching $3.43 billion by 2030, with a compound annual growth rate (CAGR) of 17.7%. This expansion during the forecast period can be attributed to a heightened need for precision drug discovery, increasing investments in gene therapy research, broader applications for disease modeling, a rising adoption of bioinformatics-driven screening, and strengthened collaboration between academia and industry. Prominent trends expected in this timeframe include a growing demand for targeted gene validation screens, increased deployment of high-throughput arrayed crispr assays, greater integration of phenotypic data analytics, an expansion of custom crispr screening services, and an enhanced emphasis on the accuracy of functional genomics.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=33018&type=smp
Which Growth Factors Are Strengthening The Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Landscape?
An elevated emphasis on personalized medicine is anticipated to stimulate the expansion of the arrayed clustered regularly interspaced short palindromic repeats (CRISPR) screening market in the coming years. This medical discipline tailors therapeutic and preventative methods according to a person’s unique genetic makeup, biological factors, and lifestyle attributes. Its uptake is growing, driven by advancements in genomics and molecular diagnostics, enabling therapies to be precisely matched to an individual’s genetic profile for improved results. Arrayed CRISPR screening supports personalized medicine through the systematic evaluation of how particular gene edits influence individual cell reactions. This facilitates the discovery of patient-specific drug targets, the forecasting of treatment effectiveness, and the creation of customized therapies informed by an individual’s genetic and cellular characteristics. As an illustration, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA cleared 16 novel personalized treatments for patients with rare diseases in 2023, an increase from six approvals in 2022. Among the personalized treatments sanctioned in 2023 were also seven medications for cancer and three for various other illnesses and states. Consequently, the heightened emphasis on personalized medicine is propelling the expansion of the arrayed clustered regularly interspaced short palindromic repeats (CRISPR) screening market.
Which Segment Groups Define The Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Landscape?
The arrayed clustered regularly interspaced short palindromic repeats (crispr) screening market covered in this report is segmented –
1) By Product Type: Clustered Regularly Interspaced Short Palindromic Repeats Libraries; Reagents And Consumables; Instruments; Software And Services
2) By Application: Functional Genomics; Drug Discovery; Disease Modeling; Gene Validation; Other Applications
3) By End User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Contract Research Organizations; Other End Users
Subsegments:
1) By Clustered Regularly Interspaced Short Palindromic Repeats Libraries: Genome Wide Knockout Libraries; Targeted Gene Libraries; Activation Libraries; Repression Libraries; Custom Designed Libraries
2) By Reagents And Consumables: Guide Ribonucleic Acid Reagents; Cas Enzyme Reagents; Transfection Reagents; Cell Culture Reagents; Assay And Detection Reagents
3) By Instruments: Automated Liquid Handling Systems; High Throughput Screening Systems; Cell Imaging Systems; Flow Cytometry Instruments; Genomic Analysis Instruments
4) By Software And Services: Screening Design Software; Data Analysis Software; Bioinformatics Services; Screening Execution Services; Custom Assay Development Services
What Trends Are Driving Changes In The Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market?
Companies operating in the arrayed clustered regularly interspaced short palindromic repeats (CRISPR) screening market are concentrating on forging strategic partnerships to enhance the precision of high-throughput phenotypic screening. A strategic partnership represents a formal collaboration where organizations pool resources, expertise, or technologies to attain shared goals, facilitating faster innovation, mitigating risk, and broadening market reach without requiring a merger or acquisition. For instance, in November 2023, AstraZeneca Plc, a UK-based science-led biopharmaceutical company, collaborated with the Medical Research Council (MRC), a UK-based government agency, and the Milner Therapeutics Institute (MTI) at the University of Cambridge, a UK-based biomedical research institute, to launch a Functional Genomics Screening Laboratory (FGSL). This state-of-the-art facility is dedicated to advancing drug discovery by mapping gene-phenotype relationships in chronic conditions such as cardiovascular and metabolic disorders, thereby boosting UK genomics leadership through open academic collaborations. Key advantages include high-throughput automation for accurate imaging and phenotyping in organoids or iPSCs, surpassing the effectiveness of pooled methods; benefits extend to providing free access for researchers, accelerating target validation, and sharing expertise to expedite the development of therapies.
Who Are The Businesses Driving Activity In The Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market?
Major companies operating in the arrayed clustered regularly interspaced short palindromic repeats (crispr) screening market are Thermo Fisher Scientific Inc, Merck KGaA, GE HealthCare Technologies Inc, Applied Biological Materials Inc, Agilent Technologies Inc, Charles River Laboratories International Inc, Integrated DNA Technologies Inc, GenScript Biotech Corporation, Synthego Holdings LLC, Santa Cruz Biotechnology Inc, Creative Biolabs Inc, VectorBuilder Inc, Admera Health LLC, Addgene Inc, Ncardia, BioCat GmbH, Cellecta Inc, GeneCopoeia Inc, Creative Biogene Inc, and Aelian Biotechnology.
Access The Complete Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Report:
Which Region Contributes The Most To The Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market?
North America was the largest region in the arrayed clustered regularly interspaced short palindromic repeats (CRISPR) screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arrayed clustered regularly interspaced short palindromic repeats (crispr) screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Report for Deeper Competitive Insights
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
